Y. Lau Et Al. , "Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.," Vaccine , vol.40, pp.2184-2190, 2022
Lau, Y. Et Al. 2022. Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.. Vaccine , vol.40 , 2184-2190.
Lau, Y., Fan Leung, T., Sirvan Cetin, B., Cagri Dinleyici, E. Ç., Huang, L., Halperin, S. A., ... Hsiao, C.(2022). Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.. Vaccine , vol.40, 2184-2190.
Lau, Yu-Lung Et Al. "Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.," Vaccine , vol.40, 2184-2190, 2022
Lau, Yu-Lung Et Al. "Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.." Vaccine , vol.40, pp.2184-2190, 2022
Lau, Y. Et Al. (2022) . "Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.." Vaccine , vol.40, pp.2184-2190.
@article{article, author={Yu-Lung Lau Et Al. }, title={Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study.}, journal={Vaccine}, year=2022, pages={2184-2190} }